Close

Rating History for Trevi Therapeutics (TRVI) by Aegis Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/29/2022 Nathan Weinstein New Coverage Buy
(N/A)
10.00
(N/A)
2.16
(1.79)
-17.13% Details